PhysiTel broadens telemedicine linePhysiTel is broadening its product line to include imaging equipment and peripheral devices for use in telemedicine and medical imaging, according to the Houston-based company. PhysiTel currently develops
PhysiTel is broadening its product line to include imaging equipment and peripheral devices for use in telemedicine and medical imaging, according to the Houston-based company. PhysiTel currently develops Internet-based telemedicine and medical communications software, and the addition of equipment and hardware will provide customers greater access to turnkey solutions, according to the company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.